Richard A Dixon

Title: Richard A. Dixon: Innovator in Leukotriene Research

Introduction

Richard A. Dixon is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of biochemistry, particularly in the study of leukotrienes. His work has implications for understanding various physiological processes and potential therapeutic targets.

Latest Patents

Richard A. Dixon holds a patent for the 5-lipoxygenase activating protein (FLAP). This 18kD protein has been isolated from rat and human cells and is essential for the production of leukotrienes from arachidonic acid in mammalian cells containing 5-lipoxygenase. Additionally, the gene (cDNA) encoding for FLAP has also been produced, showcasing his innovative approach to biochemistry.

Career Highlights

Throughout his career, Dixon has worked with prominent companies such as Merck & Co., Inc. and Merck Frosst Canada, Inc. His experience in these organizations has allowed him to contribute to significant advancements in pharmaceutical research and development.

Collaborations

Some of his notable coworkers include John W. Gillard and Jacques-Yves Gauthier. Their collaborative efforts have likely enhanced the research outcomes in their respective fields.

Conclusion

Richard A. Dixon's work in the field of leukotriene research exemplifies the impact of innovative thinking in biochemistry. His contributions continue to influence the understanding of important biological processes.